Mo1219 EPIGENETICALLY REGULATED GENE ENHANCERS AS NOVEL RATIONAL THERAPEUTIC TARGETS TO IMPEDE COLORECTAL CANCER PROGRESSION

Xinxin Shao(Shandong University of Technology), Sudipto Das(National Cancer Institute), Neville E. Sanjana(New York Genome Center), Gráinne Kirwan, Christina M. Caragine(New York Genome Center), Paulien Van Minsel, Flavia Genua, Bernard Thienpont(Center for Human Genetics), Sarah Maguire(Breast Cancer Now), Ellen Finnegan
Gastroenterology
May 1, 2024
10.1016/s0016-5085(24)02738-0
Cited by 0

Related Papers

Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
|Cell|2015|934
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
|Nature|2016|662
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing
|Nature Genetics|2016|467
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
|Cancer Discovery|2017|336
Transcription control by the ENL YEATS domain in acute leukaemia
|Nature|2017|328